ClinicalTrials.gg
Drug

Ketorolac clinical trials

Includes 95 studies of Ketorolac Tromethamine.

studies test it
299
open now
42
in phase 3
53
first study started
1999

How each study uses Ketorolac is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ketorolac studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Nov 1989 · TORADOL · NDA 019698 (FDA, Drugs@FDA; as Ketorolac Tromethamine)
European Union
28 Jul 2015 · Omidria · EMEA/H/C/003702 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ketorolac
135
Toradol
64
Acular
7
IV ketorolac
6
Acular LS
6

Development codes

PRO-156
1

In one entry with another drug

Given together, or one or the other

ropivacaine, ketorolac and epinephrine
2

Studies by the year they started

294 studies that test it; most in 2019 (21)

Studies that test Ketorolac, by start year
YearStudies
19991
20002
20011
20021
20031
20042
20057
20068
200716
200813
200916
20108
20117
201218
20138
201410
201516
201617
201715
201816
201921
202012
202117
202214
202311
202414
202515
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
11
Phase 1
28
Phase 2
50
Phase 3
53
Phase 4
130
No phase
42

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 34 · Other 265

Egalet Ltd (13) · Cairo University (7) · Henry Ford Health System (6) · Assiut University (6) · Montefiore Medical Center (5) · University Hospitals Cleveland Medical Center (5) · Innovative Medical (5) · The Cleveland Clinic (4)

Often tested with

Tested in the same studies.

Acetaminophen (26) · Ropivacaine (16) · Ibuprofen (13) · Gabapentin (13) · Bupivacaine (13) · Epinephrine (11) · Morphine (11) · Lidocaine (11)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Ketorolac is the comparator. A study of two new drugs counts under both.

  • 1Liposomal Bupivacaine · Wake Forest University Health Sciences · next primary completion Oct 2027
  • 1Bupivacaine · Wake Forest University Health Sciences · next primary completion Oct 2027
Reaching primary completion within a year · 23, 6 in phase 3

Studies that test Ketorolac, phase 3 first.

Studies

Open first, then newest update. How each study uses Ketorolac is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 299

See all 299 studies that test Ketorolac →

Given beside what is tested · 33 — Ketorolac is usual care or a partner of the new treatment

Showing 20 of 33.

As the comparator · 41 — what is tested is compared with Ketorolac

Showing 20 of 41.

Codes

What other systems call Ketorolac · ClinicalTrials.gg INT008779

  • MeSH (NLM) D020910KetorolacConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) YZI5105V0LKETOROLACConfirmed FDA, NLM, Wikidata
  • RxNorm 35827Confirmed FDA, Wikidata
  • Wikidata Q2014797ketorolacConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1219KetorolacOne source FDA
  • DrugBank DB00465One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.